FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ)

$35.21 0.3466 (0.9942%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 52

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) News Sources

ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook

17-07-2025

yahoo.com

Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit

26-09-2025

yahoo.com

ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook

16-10-2025

yahoo.com

Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month

13-11-2025

yahoo.com

Pharma ETFs in Spotlight Following Robust Q3 Earnings Results

14-11-2025

yahoo.com

FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) Sentiment Trend

0 25 50 75 100 56 4 80 59 63 17-07-2025 26-09-2025 16-10-2025 13-11-2025 14-11-2025 #1 #2 #3 #4 #5 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) FAQs

toggle

What is the current price of FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ)?

The current price of FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) is $35.21.


toggle

FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) absolute price change since previous trading day?

The absolute price change of FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) since the previous trading day is $0.3466.


toggle

FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) percentage price change since previous trading day?

The percentage price change of FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) since the previous trading day is 0.9942%.


toggle

What is the most recent average sentiment score for FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ)?

The most recent average sentiment score for FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) is 52 out of 100.


toggle

What is the most recent average sentiment for FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ)?

The most recent sentiment for FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ) is .


SEC-8K** Filing Available For FIRST TRUST NASDAQ PHARMACEU (FTXH:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.